Bezafibrate at clinically relevant doses decreases serum/liver triglycerides via down-regulation of sterol regulatory element-binding protein-1c in mice: a novel peroxisome proliferator-activated receptor alpha-independent mechanism
(Q37199135)
scientific article published on 05 January 2009
scientific article published on 05 January 2009
Language: